MarketPulse

AUCATZYL

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Autolus Therapeutics Plc

Autolus Therapeutics Posts $74.3M Revenue as AUCATZYL Scales Across Europe

Autolus Therapeutics reported $74.3M in 2025 AUCATZYL revenue with UK launch underway. Company projects $120-135M in 2026 revenue and positive gross margin expansion.
AUTLFDA approvalclinical trials
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Autolus to Present Pipeline Updates at Spring Healthcare Conferences

Autolus to present pipeline updates and 2025 financial results at two March 2026 healthcare conferences, discussing commercial progress and strategic priorities.
AUTLinvestor conferencebiopharmaceutical